How do you manage HR+HER2 negative ILC metastatic recurrence in a post-menopausal woman with extensive GI involvement complicated by a small bowel obstruction?
Patient was on tamoxifen when progression occurred; unable to tolerate adjuvant AI.
Community PollStarted
How do you treat HR+HER2 negative ILC metastatic recurrence in a post-menopausal woman with extensive GI involvement (complicated by a small bowel obstruction)?
69 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Avita Health System
Answered on
I think the answer to this question depends on a few factors. The management and outcome of patients with malignant bowel obstruction is described quite well by Tuca et al., PMID 22904637. The type of therapy I try would be influenced by their overall condition. Certainly, I would consider this an "...
Join for free or sign in to see the full answer